Jazz Pharmaceuticals plc — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2012-01-11

Reporting Person: MOMTAZEE JAMES C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-11	Common Stock	M	12500	$8.23	Acquired	12500	Direct
2012-01-11	Common Stock	F	2116	$48.60	Disposed	10384	Direct
2012-01-11	Common Stock	M	12500	$34.99	Acquired	22884	Direct
2012-01-11	Common Stock	F	8999	$48.60	Disposed	13885	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-11	Option (right to buy)	$8.23	M	12500	Disposed	2020-08-25	Common Stock (12500)	Direct
2012-01-11	Option (right to buy)	$34.99	M	12500	Disposed	2021-11-04	Common Stock (12500)	Direct

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price.

F2: The Reporting Person is a member of the Issuer's board of directors and is an executive of Kohlberg Kravis Roberts & Co. L.P. and/or one or more of its affiliates. The Reporting Person disclaims beneficial ownership of any securities beneficially owned by affiliates of Kohlberg Kravis Roberts & Co. L.P., except to the extent of his pecuniary interest therein.

F3: This nonstatutory stock option vested in 12 equal monthly installments from August 15, 2010.

F4: This nonstatutory stock option has a vesting schedule of 100% vesting in 12 equal monthly installments from August 15, 2011.

F5: On October 24, 2011, the Board of Directors of the Issuer approved the full vesting of unvested nonstatutory stock options held by the Issuer's officers and non-employee directors, including the Reporting Person. Such vesting acceleration became effective on December 13, 2011.